Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares stood at 3.08 million during the last session, with the company’s beta value hitting 0.34. At the close of trading, the stock’s price was $0.35, to imply an increase of 2.68% or $0.01 in intraday trading. The APDN share’s 52-week high remains $22.80, putting it -6414.29% down since that peak but still an impressive 20.0% since price per share fell to its 52-week low of $0.28. The company has a valuation of $3.59M, with an average of 3.81 million shares in intraday trading volume over the past 10 days and average of 10.65 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Applied Dna Sciences Inc (APDN), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give APDN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.34.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
After registering a 2.68% upside in the last session, Applied Dna Sciences Inc (APDN) has traded red over the past five days. The 5-day price performance for the stock is 10.86%, and -63.55% over 30 days. With these gigs, the year-to-date price performance is -97.18%. Short interest in Applied Dna Sciences Inc (NASDAQ:APDN) saw shorts transact 1.74 million shares and set a 0.48 days time to cover.
The extremes give us $1.5 and $1.5 for target low and target high price respectively. As such, APDN has been trading -328.57% off suggested target high and -328.57% from its likely low.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Looking at statistics comparing Applied Dna Sciences Inc share performance against respective industry, we note that the company has outperformed competitors. Applied Dna Sciences Inc (APDN) shares are -92.71% down over the last 6 months, with its year-to-date growth rate higher than industry average at 88.16% against 14.10%. Revenue is forecast to grow 93.50% this quarter before jumping 82.20% for the next one. The rating firms project that company’s revenue will shrink -73.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 900k. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 1.04M.Earnings reports from the last fiscal year show that sales brought in 780k and 891k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 15.40% before jumping 16.70% in the following quarter.
APDN Dividends
Applied Dna Sciences Inc has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Applied Dna Sciences Inc insiders hold 3.04% of total outstanding shares, with institutional holders owning 11.86% of the shares at 12.23% float percentage. In total, 11.86% institutions holds shares in the company, led by MATHER GROUP, LLC.. As of 2024-06-30, the company held over 700.0 shares (or 0.0803% of shares), all amounting to roughly $287.0.
